Han Rui, Li Wanqiu, Tian Hui, Zhao Yun, Zhang Hui, Pan Wei, Wang Xianyi, Xu Linfeng, Ma Zhongliang, Bao Zhijun
Department of Emergency, Huadong Hospital, Fudan University, Shanghai 200040, P.R. China.
Laboratory for Noncoding RNA & Cancer, School of Life Sciences, Shanghai University, Shanghai 200444, P.R. China.
Exp Ther Med. 2023 May 26;26(1):346. doi: 10.3892/etm.2023.12045. eCollection 2023 Jul.
Renal dysfunction is a common complication of sepsis. Early diagnosis and prompt treatment of sepsis with renal insufficiency are crucial for improving patient outcomes. Diagnostic markers can help identify patients at risk for sepsis and AKI, allowing for early intervention and potentially preventing the development of severe complications. The aim of the present study was to investigate the expression difference of urinary microRNAs (miRNAs/miRs) in elderly patients with sepsis and secondary renal insufficiency, and to evaluate their diagnostic value in these patients. In the present study, RNA was extracted from urine samples of elderly sepsis-related acute renal damage patients and the expression profiles of several miRNAs were analyzed. In order to evaluate the expression profile of several miRNAs, urine samples from elderly patients with acute renal damage brought on by sepsis were obtained. RNA extraction and sequencing were then performed on the samples. Furthermore, multiple bioinformatics methods were used to analyze miRNA profiles, including differential expression analysis, and Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analysis of different miRNA target genes, to further explore miRNAs that are suitable for utilization as biomarkers. A total of four miRNAs, including hsa-miR-31-5p, hsa-miR-151a-3p, hsa-miR-142-5p and hsa-miR-16-5p, were identified as potential biological markers and were further confirmed in sepsis using reverse transcription-quantitative PCR. The results of the present study demonstrated that the four urinary miRNAs were differentially expressed and may serve as specific markers for prediction of secondary acute kidney injury in elderly patients with sepsis.
肾功能障碍是脓毒症的常见并发症。早期诊断并及时治疗伴有肾功能不全的脓毒症对于改善患者预后至关重要。诊断标志物有助于识别脓毒症和急性肾损伤(AKI)的高危患者,从而实现早期干预并有可能预防严重并发症的发生。本研究的目的是调查老年脓毒症继发肾功能不全患者尿中微小RNA(miRNA/miR)的表达差异,并评估其对这些患者的诊断价值。在本研究中,从老年脓毒症相关急性肾损伤患者的尿液样本中提取RNA,并分析了几种miRNA的表达谱。为了评估几种miRNA的表达谱,获取了老年脓毒症所致急性肾损伤患者的尿液样本。然后对样本进行RNA提取和测序。此外,还使用了多种生物信息学方法分析miRNA谱,包括差异表达分析以及对不同miRNA靶基因的基因本体论和京都基因与基因组百科全书富集分析,以进一步探索适合用作生物标志物的miRNA。总共鉴定出四种miRNA,包括hsa-miR-31-5p、hsa-miR-151a-3p、hsa-miR-142-5p和hsa-miR-16-5p作为潜在生物标志物,并使用逆转录定量PCR在脓毒症中进一步进行了验证。本研究结果表明,这四种尿miRNA存在差异表达,可能作为老年脓毒症患者继发性急性肾损伤预测的特异性标志物。